NCT06729762 Ultrasound-guided Thermal Ablation for Benign Thyroid Nodules
| NCT ID | NCT06729762 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese PLA General Hospital |
| Condition | Thyroid Nodule (Benign) |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,500 participants |
| Start Date | 2024-12-09 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,500 participants in total. It began in 2024-12-09 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To evaluate long-term outcomes of ultrasound-guided thermal ablation for benign thyroid nodules
Eligibility Criteria
Inclusion Criteria: 1. confirmation of benign nodule status on two separate fine- needle aspiration or core-needle biopsy 2. no suspicious malignant features on ultrasound examination 3. report of cosmetic and/ or symptomatic problems or concern of nodules growing rapidly or malignant transformation 4. refusal or ineligibility for surgery 5. follow-up time ≥12 months Exclusion Criteria: 1. follicular neoplasm or malignancy findings on biopsy 2. nodules with benign result on biopsy had suspicious of malignancy in US 3. patients with contra-lateral vocal cord paralysis 4. previous radiation to the head and neck 5. follow- up time less than 12 months
Contact & Investigator
Yukun Luo
PRINCIPAL INVESTIGATOR
Chinese PLA General Hospital
Frequently Asked Questions
Who can join the NCT06729762 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Thyroid Nodule (Benign). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06729762 currently recruiting?
Yes, NCT06729762 is actively recruiting participants. Contact the research team at gemma-y@163.com for enrollment information.
Where is the NCT06729762 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06729762 clinical trial?
NCT06729762 is sponsored by Chinese PLA General Hospital. The principal investigator is Yukun Luo at Chinese PLA General Hospital. The trial plans to enroll 1,500 participants.